Grab your favorite coffee. This is where you’ll find all the substance you require, and more.
Introducing Cognivia Signal: Real-Time Behavioral Risk Intelligence for Clinical Trials
Cognivia launches the world’s first real-time behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia, the AI-driven leader in behavioral science for clinical research, proudly announces the launch of Cognivia Signal, a groundbreaking solution…
Bayesian Modeling Of The Placebo Response In Neuropathic Pain
In analgesia randomized clinical trials (RCTs), the magnitude and the variability of the placebo response have a negative…
Multifactorial Aspect Of The Placebo Analgesia Response In Peripheral Neuropathic Patients
The placebo response exerts a confusing influence when testing the statistically significant superiority of active compounds compared to…
Characterization And Prediction Of Placebo Responders In Peripheral Neuropathic Patients In A 4-week Analgesic Clinical Trial
In analgesia randomized clinical trials (RCTs), the magnitude of the placebo response tends to increase with the year…
Do Environmental Parameters Influence The Prediction Of The Placebo Response?
This proof-of-concept study on peripheral neuropathic pain patients investigates the potential influence of the investigator on the placebo…
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields